Unmet weight loss targets in real-world clinical practice: weight management and perceptions in China

被引:1
|
作者
Lin, Ziwei [1 ]
Si, Si [1 ]
Liu, Jia [2 ]
Zhu, Hao [1 ]
Xu, Jiawei [1 ]
Artime, Esther [3 ]
Khare, Swarna [4 ]
Higgins, Victoria [5 ]
Leith, Andrea [5 ]
Qu, Shen [2 ,6 ]
机构
[1] Eli Lilly & Co, Suzhou, Peoples R China
[2] Tongji Univ, Shanghai Peoples Hosp 10, Endocrinol & Metab Ctr, Sch Med, Shanghai, Peoples R China
[3] Eli Lilly & Co, Alcobendas, Spain
[4] Eli Lilly & Co, Bracknell, England
[5] Adelphi Real World, Bollington, England
[6] SinoUnited Hlth, Endocrinol Metab & Thyroid Ctr, Shanghai, Peoples R China
来源
关键词
China; dietary intervention; obesity therapy; real-world evidence; weight control; OBESITY; OVERWEIGHT;
D O I
10.3389/fendo.2024.1470394
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To describe weight management and perceptions in China.Materials and methods Data were from the Adelphi Real World Obesity Disease Specific Programme (TM), a cross-sectional survey between April and July 2022 of physicians managing people with obesity or overweight (PwO) and PwO in real-world clinical practice in China. At data collection, eligible PwO were aged >= 18 years, under weight management and/or had a body mass index (BMI) >= 28 kg/m2.Results In total, 100 physicians and 801 PwO were enrolled. More than two thirds of PwO (70.7%; 531/751) were not diagnosed with obesity until a BMI >= 30 kg/m2. Most PwO (78%; 625/801) were on treatment for at least one obesity-related complication (ORC). Physicians commonly initiated weight loss discussions with PwO who already had an ORC (48.0%; 48/100). According to physicians and PwO, the mean target BMI was set at 25.8 kg/m2 and 24.3 kg/m2, and the mean target percentage weight loss was 19.6% and 23.7%, respectively. Over a median 6.4 months of weight management, the mean percentage weight loss was 4.1%. Few PwO achieved the weight loss target set by their physician (9.9%; 69/695) or themselves (2.0%; 14/696). Most physicians and PwO were unsatisfied with the current weight loss (92.3% [739/801] and 82.0% [650/793], respectively).Conclusions These findings suggest that earlier intervention may be needed to address obesity as a disease. Most physicians and PwO recognized the importance of normal weight, but few PwO achieved weight loss targets, which may suggest an unmet need for improved weight management.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Clinical effectiveness of liraglutide on weight loss in South Koreans First real-world retrospective data on Saxenda in Asia
    Park, Joon Seok
    Kwon, Jieun
    Choi, Hyung Jin
    Lee, Changhyun
    MEDICINE, 2021, 100 (02) : E23780
  • [22] Long-term weight outcomes in patients treated with liraglutide 3.0 mg in real-world clinical practice
    Grannell, Andrew
    Al-Najim, Werd
    le Roux, Carel
    CLINICAL OBESITY, 2023,
  • [23] Long-term weight outcomes in patients treated with liraglutide 3.0 mg in real-world clinical practice
    Grannell, Andrew
    Al-Najim, Werd
    le Roux, Carel
    CLINICAL OBESITY, 2024, 14 (01)
  • [24] Recruitment and reach in a pragmatic behavioral weight loss randomized controlled trial: implications for real-world primary care practice
    Christie A. Befort
    Danny Kurz
    Jeffrey J. VanWormer
    Edward F. Ellerbeck
    BMC Family Practice, 21
  • [25] Recruitment and reach in a pragmatic behavioral weight loss randomized controlled trial: implications for real-world primary care practice
    Befort, Christie A.
    Kurz, Danny
    VanWormer, Jeffrey J.
    Ellerbeck, Edward F.
    BMC FAMILY PRACTICE, 2020, 21 (01)
  • [26] Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland
    Haase, Christiane Lundegaard
    Serratore Achenbach, Maria Giovanna
    Lucrezi, Gianluca
    Jeswani, Nikita
    Maurer, Susanne
    Egermann, Ulrich
    OBESITY FACTS, 2021, 14 (05) : 568 - 576
  • [27] Weight Management in Patients with Type 2 Diabetes: a Multidisciplinary Real-world Approach
    Hamdy, Osama
    Ashrafzadeh, Sahar
    Mottalib, Adham
    CURRENT DIABETES REPORTS, 2018, 18 (09)
  • [28] Weight Management in Patients with Type 2 Diabetes: a Multidisciplinary Real-world Approach
    Osama Hamdy
    Sahar Ashrafzadeh
    Adham Mottalib
    Current Diabetes Reports, 2018, 18
  • [29] Effect of weight loss on proteinuria in adults with type 2 diabetes: A real-world study
    Ren, Wenqian
    Gong, Yujia
    Zhen, Qin
    Gu, Liping
    Yang, Jiaying
    Kang, Mei
    Zhang, Aifang
    Shen, Tingting
    Wang, Yufan
    Liu, Fang
    Li, Na
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 206
  • [30] Real-World Evidence Study of Naltrexone/Bupropion for Achieving Clinically Significant Weight Loss
    Arora, Mansi
    Rajasekharan, Shruti
    Rohela, Pallavi
    Sandhu, RajanPaul
    Naidu, Rishi
    Hamm, Caroline
    Naidu, Padmaja
    OBESITY, 2024, 32 : 191 - 192